• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Mullooly-Logo

Mullooly Asset Management

Fiduciary Fee-Only Financial Planner | Investment Advisor in Wall, NJ

  • Our Fees
  • About us
  • Schedule a Meeting

Is Biotech The Next Sector To Make A Move?

March 30, 2012 by Thomas Mullooly

https://media.blubrry.com/invest/p/mullooly.net/wp-content/uploads/2012/03/March-30-2012-Podcast.mp3

Subscribe: RSS

With the stock market at overbought levels, finding the right sector to put money to work becomes more important than ever. With this in mind, we look at what happened with homebuilders, and how that sector moved from an average stock market performer, to an over achieving sector.

We noticed that the bullish percent index for the homebuilder sector turned positive, in late November/early December 2011. We also observed that the percent of homebuilder companies in a positive trend also turned positive at the same time. Additionally, we noticed the percentage of companies with improving relative strength turned to X’s shortly thereafter.

While the experts were still telling investors to avoid the home building sector, in the past three months this sector rose 22%. Now these same experts are calling the bottom of the housing market and recommending investments.

This is why it can be very damaging to your portfolio (and damaging to your investment returns), if you pay too much attention to what the media is reporting.

The media — even the financial media — can often be way behind the curve. Most of Main Street investing, however follows the financial media. This is one reason why I continue to employ the use of point figure charts to manage your money. It’s important to see which sectors and which specific names are starting to see increased demand (and which other names are starting to see an increase in supply), and then move accordingly.

Using this same approach, we have begun to notice increased demand in the biotech sector.

We’ve noticed that the bullish percent index for the biotechnology sector has turned positive. We also observed the percent of biotechnology companies in a positive trend has also turned positive. Finally, we have noticed the percentage of companies in the biotech sector with improving relative strength continues to increase. This certainly helps put the biotechnology sector of the NYSE on our radar scope.

If you are relying on a blog post for specific investment advice, you are making a huge mistake. Please speak with an investment adviser before making ANY investment decisions.
If you do not have an investment adviser, we encourage you to contact Mullooly Asset Management at 732-223-9000, or through our website. Under no circumstances should the content discussed here to be considered specific investment advice.

Never miss a post...and we deliver!

newsletter mailman

Get our updates delivered right to your inbox. Sign up today!

Success! Now go and check your email to confirm your subscription.

There was an error submitting your subscription. Please try again.

We won't send you spam. Unsubscribe at any time. Powered by ConvertKit

Filed Under: Point and Figure, Stock Market Comments

About Thomas Mullooly

Thomas Mullooly is owner and founder of Mullooly Asset Management, Inc. In 2002 Tom opened Mullooly Asset Management, a fee-only investment advisory firm. As an investment advisor, and not a broker, Tom works strictly for his clients. With the help of point and figure charting, Tom builds a realistic game plan for clients.

Footer

Mullooly-Logo

2052 NJ-35, Suite #203
Wall Township, NJ 07719
Phone: (732) 223-9000
Fax: (732) 223-9600
Email: support@mullooly.net

Form CRS

  • Privacy Policy
  • Disclosures and Legal Disclaimers

Useful Links

  • Contact Us
  • Client Login
  • Pay Bill Online
  • About us
  • Our Fees

The information on this website and blog do not involve the rendering of personalized investment advice. A professional advisor should be consulted before implementing any of the options presented. None of the content contained in this website should be construed as legal or tax advice. Always consult an attorney or tax professional regarding your specific legal or tax situation.

Follow Us

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Resource Center

  • Videos
  • Podcasts
  • Blog

Copyright © 2021